Literature DB >> 18259987

Expression, activity and regulation of CYP3A in human and rodent brain.

C Woodland1, T T Huang, E Gryz, R Bendayan, J P Fawcett.   

Abstract

The importance of cytochrome P450 (CYP) 3A enzymes in human drug metabolism is well established. The function of these enzymes has been characterized extensively in liver and intestinal tissues but much less is known about their expression, regulation and functional activity in the brain. Several lines of evidence point to the presence and function of multiple forms of CYP enzymes, including CYP3A, in both human and rodent brain. Expression studies suggest that CYP3A enzymes show regional differences in their distribution in the brain, where they may play a role in steroid metabolism. They also metabolize many psychoactive drugs and may have a profound effect on their efficacy and safety. This review explores the tissue, cellular, and subcellular expression of CYP3A isoforms in human and rodent brain and provides insight into their functional roles and regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259987     DOI: 10.1080/03602530701836712

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  15 in total

1.  Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration.

Authors:  Sebastien Carnicella; Dao-Yao He; Quinn V Yowell; Stanley D Glick; Dorit Ron
Journal:  Addict Biol       Date:  2010-10       Impact factor: 4.280

Review 2.  Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases.

Authors:  Chaitali Ghosh; Vikram Puvenna; Jorge Gonzalez-Martinez; Damir Janigro; Nicola Marchi
Journal:  Curr Drug Metab       Date:  2011-10       Impact factor: 3.731

Review 3.  Statins and neuroprotection: basic pharmacology needed.

Authors:  W Gibson Wood; Walter E Mΰller; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2014-01-29       Impact factor: 5.590

4.  Vitamin D receptor activation induces P-glycoprotein and increases brain efflux of quinidine: an intracerebral microdialysis study in conscious rats.

Authors:  Matthew R Durk; Jianghong Fan; Huadong Sun; Yingbo Yang; Henrianna Pang; K Sandy Pang; Inés A M de Lannoy
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

5.  Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures.

Authors:  Leonie Runtz; Benoit Girard; Marion Toussenot; Julie Espallergues; Alexis Fayd'Herbe De Maudave; Alexandre Milman; Frederic deBock; Chaitali Ghosh; Nathalie C Guérineau; Jean-Marc Pascussi; Federica Bertaso; Nicola Marchi
Journal:  Epilepsia       Date:  2017-11-10       Impact factor: 5.864

6.  In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.

Authors:  Md Tozammel Hoque; Arpit Shah; Vijay More; David S Miller; Reina Bendayan
Journal:  J Neurochem       Date:  2015-11-13       Impact factor: 5.372

7.  CNO Evil? Considerations for the Use of DREADDs in Behavioral Neuroscience.

Authors:  Stephen V Mahler; Gary Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2018-02-07       Impact factor: 7.853

8.  Cytochrome p450 mRNA expression in the rodent brain: species-, sex-, and region-dependent differences.

Authors:  Marianna Stamou; Xianai Wu; Izabela Kania-Korwel; Hans-Joachim Lehmler; Pamela J Lein
Journal:  Drug Metab Dispos       Date:  2013-11-19       Impact factor: 3.922

9.  The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6.

Authors:  Natasha T Snider; Matthew J Sikora; Chitra Sridar; Thomas J Feuerstein; James M Rae; Paul F Hollenberg
Journal:  J Pharmacol Exp Ther       Date:  2008-08-12       Impact factor: 4.030

10.  Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs.

Authors:  Annalisa Nannelli; Francesco Rossignolo; Roberto Tolando; Paolo Rossato; Mario Pellegatti; Vincenzo Longo; P Giovanni Gervasi
Journal:  Mol Cell Biochem       Date:  2009-10-22       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.